Base4 Biotechnology focuses on RNA-modulating small molecules and employs a structure-based approach to address RNA targets using their proprietary VERITAS Platform. The platform is AI-enhanced and designed to discover selective molecules against druggable RNA regions.

Base4 Biotechnology

Euro

Amazon

Google Apps for Business

GoDaddy DNS

AWS Global Accelerator

GoDaddy Premium DNS

CEO, Chairman, Founder

Joshua Fairbank

Vice President

Isaac Kimsey

Board of Directors/ Past-CEO

Mike Pape

Sales and Support

Yang Zheng

Scientist

Eric Szymanski

Research Scientist

Hala Abou Assi

Research Associate

Richard Nelson

Head of BD

Josh Fairbank

Biotechnology Seed Stage Companies With Fewer Than 100 Employees

Biotechnology Companies With Less Than $50M in Revenue (Top 10K)

North Carolina Companies With Less Than $50M in Revenue (Top 10K)

Southern US Seed Stage Companies With Less Than $500M in Revenue

Base4 is redefining RNA-targeted therapeutics through novel small molecule modulation to go after previously untreatable diseases. Powered by our revolutionary structure-based discovery platform, we are solving complicated diseases in several disease areas including neurology, oncology, and rare diseases.

Grant - Base4 Biotechnology

Seed Round - Base4 Biotechnology

Durham

North Carolina

United States

North America

U-M’s MADE Program Aims to Train Entrepreneurs in Developing Nations

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 6, 2024 11:17 PM	8e5bddc9
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 6, 2024 11:17 PM	54cde7b5
crunchbase trigger	general	Nov 6, 2024 11:17 PM	cfb71db1
crunchbase profile	general	Nov 7, 2024 6:30 PM	3635d36e
li profile	general	Nov 6, 2024 11:17 PM	a6371ee8
translate crunchbase fundingrounds	general	Nov 7, 2024 7:12 PM	734557b2
peers	general	Nov 6, 2024 11:17 PM	d78305e0
news basic	general	Nov 6, 2024 11:17 PM	1c6bbd4c
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

BASE

BIO:BASE4

Base4 Biotechnology